Stock Rating Upgrade
In the last week the Value Trend Rating for Haemonetics Corp (NYSE: HAE) improved from D to C reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
Haemonetics Corp (NYSE: HAE) stock closed at $77.03 on 8/9/24 after a modest gain of 0.8%. Moreover, this advance was accompanied by above average trading volume at 149% of normal. The stock has declined -14.5% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
HAE’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
Haemonetics has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Haemonetics has a slightly negative Appreciation Score of 30 and a neutral Power Rating of 59, with the Low Neutral Value Trend Rating the result.
Be the first to comment